Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

…, LA Kalish, SF Assmann, MF Para… - Annals of internal …, 2001 - acpjournals.org
Background: Mortality and morbidity related to AIDS have decreased among HIV-infected
patients taking highly active anti-retroviral therapy (HAART), but previous studies may have …

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind …

…, N Hansen, AC Collier, JT Carey, MF Para… - Annals of internal …, 1990 - acpjournals.org
Objective: To evaluate the efficacy and safety of zidovudine early in the treatment of human
immunodeficiency virus type 1 (HIV) infection. Design: A double-blind, randomized, placebo-…

Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention

…, SL Koletar, W Maher, JA Minor, BA Oglevee, MF Para… - Jama, 1996 - jamanetwork.com
Objective. —To determine the incidence and mortality rates of patients with bacteremic
infections withStreptococcus pneumoniae, and to determine the serotypes and antimicrobial …

Evolution of recurrent herpes simplex lesions. An immunohistologic study.

…, RR Turner, AC Miller, MF Para… - The Journal of …, 1985 - Am Soc Clin Investig
We performed immunoperoxidase stains on skin biopsies taken from nine patients with
recurrent peripheral herpes simplex lesions at 12 h to 6 d after onset of signs of symptoms to …

Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults

BA Smith, JL Neidig, JT Nickel, GL Mitchell, MF Para… - Aids, 2001 - journals.lww.com
Objectives The purpose of the study was to examine the effects of aerobic exercise on
physiological fatigue (time on treadmill), dyspnea [rate of perceived exertion (RPE) and forced …

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257

…, TT Brown, KB Patterson, MF Para… - Clinical Infectious …, 2015 - academic.oup.com
Background. Metabolic effects following combination antiretroviral therapy (cART) vary by
regimen type. Changes in metabolic effects were assessed following cART in the AIDS …

Psychopathology in human immunodeficiency virus infection: lifetime and current assessment

…, RA Bornstein, HA Nasrallah, MF Para… - Comprehensive …, 1993 - Elsevier
The present study determined lifetime and current psychiatric functioning in a sample of
homosexual or bisexual men at various stages of human immunodeficiency virus (HIV) infection …

[HTML][HTML] Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection

…, SH Liou, H Kessler, MF Para… - … England Journal of …, 2001 - Mass Medical Soc
Background The optimal antiretroviral treatment for patients who have human immunodeficiency
virus (HIV) viremia despite treatment with nucleoside reverse-transcriptase inhibitors (…

Neuropsychological performance in symptomatic and asymptomatic HIV infection

RA Bornstein, HA Nasrallah, MF Para, CC Whitacre… - Aids, 1993 - journals.lww.com
Objective: To examine cognitive function in patients at various stages of HIV infection, and
to determine the nature and severity associated with stage of illness. Design: Subjects were …

The duration of zidovudine benefit in persons with asymptomatic HIV infection: prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group

…, AC Collier, L Corey, RW Coombs, MF Para… - Jama, 1994 - jamanetwork.com
Objective. —To determine the durability of zidovudine-induced delay in clinical progression
of asymptomatic human immunodeficiency virus (HIV) disease and to assess the …